Rabeprazole Sodium Enteric Coated & Itopride HCl Sustained Release Capsules (20mg/150mg)
Gastrointestinal

Rabeprazole Sodium Enteric Coated & Itopride HCl Sustained Release Capsules (20mg/150mg)

Pack Sizes Available

Alu-Alu Blister: 10 x 10 Capsules
Alu-Alu Blister: 10 x 15 Capsules
Export Carton: 100 x 10 Capsules

Product Description

Domperidone gets most of the attention in PPI-prokinetic combinations, but it's not the only prokinetic in circulation, and for good reason. Itopride works through a dual mechanism, dopamine D2 receptor antagonism combined with acetylcholinesterase inhibition, which gives it a broader push on gastric motility than a single-mechanism agent, and it's increasingly the prokinetic of choice in combination therapy for functional dyspepsia. This capsule pairs Rabeprazole Sodium 20mg, delivered as enteric-coated pellets, with Itopride Hydrochloride 150mg. Rabeprazole inhibits gastric acid secretion by blocking the H+/K+ ATPase proton pump in parietal cells, while Itopride's combined action stimulates gastrointestinal propulsion and accelerates gastric emptying more comprehensively than a single-pathway prokinetic. Together they're indicated for the management of stomach acid disorders, GERD, duodenal ulcers, and functional dyspepsia where poor gastric motility is a driving factor. The capsule should be swallowed whole rather than chewed or divided, since both the enteric coating on Rabeprazole and the release mechanism depend on reaching the intestine intact. Rabeprazole is metabolized through the hepatic cytochrome P450 system, and prescribers typically account for interactions with medications like digoxin, phenytoin, or carbamazepine when this combination is used alongside other chronic therapy. For a distributor building out a gastroenterology portfolio, this SKU sits as a differentiated option alongside a Domperidone-based combination, giving prescribers and pharmacists a genuine choice of prokinetic mechanism rather than a single default. That differentiation tends to matter to hospital procurement committees and larger pharmacy chains evaluating formulary depth. We manufacture this to WHO-GMP standards with complete stability and analytical documentation, available under contract manufacturing for a buyer's own brand or supplied under our own registered label. Fifteen years of exporting pharmaceutical formulations from India means the regulatory dossier accompanying this product is built to clear registration processes cleanly, not patched together after a query comes back.

Technical Specifications

  • Composition: Rabeprazole Sodium 20mg (enteric coated pellets) + Itopride Hydrochloride 150mg (sustained release)
  • Dosage Form: Hard Gelatin Capsule
  • Drug Class: Proton Pump Inhibitor + Prokinetic (D2 antagonist + acetylcholinesterase inhibitor)
  • Recommended Dosage: 1 capsule daily or as directed by physician
  • Packaging: Alu-Alu blister, 10x10 capsules per box
  • Shelf Life: 24 months from date of manufacture
FAQ

Frequently asked questions

Contact Export TeamContact Export Team

Itopride works through a dual mechanism, combining dopamine D2 receptor antagonism with acetylcholinesterase inhibition, giving it a broader action on gastric motility compared to Domperidone's single dopamine-receptor-based mechanism.

It is indicated for stomach acid disorders, GERD, duodenal ulcers, and functional dyspepsia, particularly where impaired gastric motility contributes to symptoms.

Method of administration should follow the prescribing physician's guidance; the capsule should be swallowed whole with liquid and not chewed, divided, or crushed.

Rabeprazole is metabolized through the hepatic cytochrome P450 system and can interact with medications such as digoxin, phenytoin, carbamazepine and certain antifungals. A full medication history should be reviewed before co-prescribing.

Typically 24 months from date of manufacture when stored below 25°C, protected from moisture and light, in the original Alu-Alu blister packaging.

Yes, private label manufacturing with custom branding and blister specifications is available, backed by full WHO-GMP batch documentation for export registration.

You might also like

Related Products

Explore more high-quality items from our Gastrointestinal range.

Esomeprazole Capsule IP
Gastrointestinal

Esomeprazole Capsule IP

Acid reflux does not sound like a serious problem until someone has lived with it long enough to develop esophagitis, and that is really the gap Esomeprazole was designed to close. As the S-isomer of omeprazole, it offers a more consistent acid suppression profile than its parent compound, which is part of why it has become one of the most trusted proton pump inhibitors in gastroenterology over the past two decades. The capsule contains gastro-resistant pellets that survive the acidic environment of the stomach before dissolving further down the digestive tract, where the active drug is absorbed and goes on to block the proton pumps in the stomach lining responsible for acid secretion. This makes it effective across gastroesophageal reflux disease, erosive esophagitis, and peptic ulcer disease, and it is frequently included as part of combination therapy for eradicating H. pylori infection alongside antibiotics. Sara Wellness manufactures and exports Esomeprazole Capsules through GMP-certified Indian facilities, and over fifteen years of doing this we have learned that gastrointestinal drugs like this one move in genuinely enormous volumes across pharmacy distribution networks worldwide, which puts real pressure on a manufacturer to maintain pellet coating quality and dissolution consistency at scale. We work with partners who have already proven they can hold that line. Every buyer we work with deals with our export team directly, with no broker sitting between your order and our production schedule. Whether your business runs a small specialty pharmacy chain or manages procurement for a much larger distribution network, we structure order quantities to fit your actual needs rather than pushing a rigid minimum that only works for the biggest buyers. Shipments include certificate of analysis, GMP compliance documentation, and export paperwork built around your country's specific import rules. If Esomeprazole already features in your gastrointestinal product range, or you are looking to add a dependable PPI supplier from India, send us your target market and volume and we will respond with current pricing and honest delivery timelines.

Esomeprazole Sodium Enteric Coated & Domperidone Sustained Release Capsules
Gastrointestinal

Esomeprazole Sodium Enteric Coated & Domperidone Sustained Release Capsules

A patient walking in with heartburn, bloating, and a queasy stomach all at once is not an unusual case for a gastroenterologist, and treating that combination with two separate prescriptions has always felt like more steps than the situation needs. This capsule solves that by combining Esomeprazole, which shuts down acid production at the source, with Domperidone in a sustained release format, which helps the stomach empty faster and keeps nausea in check throughout the day. Esomeprazole's enteric coating protects it through the stomach's acidic environment so it can be absorbed further along the digestive tract, where it blocks the proton pumps responsible for acid secretion. Domperidone works through an entirely different pathway, blocking dopamine receptors in the gut to speed up gastric motility and reduce nausea, and the sustained release formulation spreads that effect across the day rather than delivering it all at once. Together, this pairing covers acid reflux with the added benefit of symptom relief for bloating, early satiety, and nausea that often rides alongside it. Sara Wellness has built a specific niche in exporting combination gastrointestinal capsules like this one across fifteen years in the pharmaceutical trade, sourcing from GMP-certified Indian manufacturers whose expertise in multi-particulate and sustained release formulation is exactly what a two-mechanism capsule like this demands. Getting both release profiles right in the same capsule shell is a genuinely different manufacturing challenge than a standard tablet, and we only work with partners who have already proven they can do it consistently. Our export relationships stay direct, without a chain of middlemen adding delay or cost to a straightforward transaction. Order quantities flex for a distributor bringing in a first trial shipment as comfortably as they do for a pharmacy chain managing a recurring monthly restock. Every shipment ships with certificate of analysis, GMP compliance certification, and export documentation tailored to your destination country. Reach out with your target market and expected volume and our team will come back with current pricing and a realistic delivery schedule.

Esomeprazole Sodium Enteric Coated & Itopride HCl Sustained Release Capsules
Gastrointestinal

Esomeprazole Sodium Enteric Coated & Itopride HCl Sustained Release Capsules

Reflux and sluggish digestion tend to show up together more often than patients expect, and prescribing Esomeprazole for the acid without addressing the underlying motility problem often leaves the patient still complaining of fullness and discomfort after meals. This capsule pairs Esomeprazole's acid suppression with Itopride HCl, a prokinetic agent that works through a dual mechanism to get the stomach moving properly again. Itopride acts as both a dopamine D2 receptor antagonist and an acetylcholinesterase inhibitor, which increases acetylcholine availability at the gut and accelerates gastric emptying without carrying some of the cardiac safety concerns associated with older prokinetic agents. Combined with Esomeprazole's proton pump inhibition, this capsule addresses functional dyspepsia and GERD together, covering the acid, the bloating, and the sense of early fullness that often frustrates patients more than the heartburn itself. Sara Wellness has exported combination gastrointestinal formulations like this one for fifteen years, working with GMP-certified Indian manufacturers who specialize in getting two distinct release profiles, enteric coating for one ingredient and sustained release for the other, to behave predictably inside a single capsule shell. That is a meaningfully harder manufacturing problem than it sounds, and we have structured our sourcing relationships specifically around partners who have already solved it. We keep the relationship with buyers personal and direct, skipping the broker layer that usually slows down communication and adds cost between an Indian manufacturer and an overseas pharmacy distributor. Our order sizes work whether you are testing this specific combination for the first time or restocking an established gastrointestinal product line. Every shipment ships with certificate of analysis, GMP compliance certification, and export paperwork prepared for your destination country's specific requirements. Send us your target market and expected volume, and we will respond with current pricing and a realistic delivery timeline.